Banco Santander’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $107M | Buy |
116,226
+3,646
| +3% | +$3.7M | 0.86% | 17 |
|
|
2025
Q4 | $121M | Buy |
112,580
+1,313
| +1% | +$1.26M | 0.91% | 20 |
|
|
2025
Q3 | $84.9M | Buy |
111,267
+24,654
| +28% | +$18.3M | 0.75% | 22 |
|
|
2025
Q2 | $67.5M | Buy |
86,613
+16,403
| +23% | +$12.7M | 0.64% | 24 |
|
|
2025
Q1 | $58M | Sell |
70,210
-8,971
| -11% | -$7.46M | 0.64% | 25 |
|
|
2024
Q4 | $61.1M | Buy |
79,181
+4,734
| +6% | +$3.92M | 0.74% | 24 |
|
|
2024
Q3 | $66M | Sell |
74,447
-1,922
| -3% | -$1.73M | 0.78% | 18 |
|
|
2024
Q2 | $69.1M | Buy |
76,369
+2,954
| +4% | +$2.36M | 0.86% | 17 |
|
|
2024
Q1 | $57.1M | Buy |
73,415
+7,996
| +12% | +$5.69M | 0.69% | 20 |
|
|
2023
Q4 | $38.1M | Buy |
65,419
+261
| +0.4% | +$152K | 0.45% | 30 |
|
|
2023
Q3 | $35M | Buy |
65,158
+14,660
| +29% | +$7.55M | 0.5% | 25 |
|
|
2023
Q2 | $23.7M | Buy |
50,498
+7,888
| +19% | +$3.31M | 0.31% | 47 |
|
|
2023
Q1 | $14.6M | Buy |
42,610
+12,156
| +40% | +$4.1M | 0.22% | 63 |
|
|
2022
Q4 | $11.1M | Sell |
30,454
-3,883
| -11% | -$1.38M | 0.16% | 75 |
|
|
2022
Q3 | $11.1M | Sell |
34,337
-318
| -0.9% | -$101K | 0.15% | 78 |
|
|
2022
Q2 | $11.2M | Buy |
34,655
+20,683
| +148% | +$6.21M | 0.15% | 81 |
|
|
2022
Q1 | $4M | Buy |
13,972
+2,514
| +22% | +$647K | 0.04% | 185 |
|
|
2021
Q4 | $3.17M | Sell |
11,458
-2,834
| -20% | -$718K | 0.02% | 203 |
|
|
2021
Q3 | $3.3M | Buy |
14,292
+2,737
| +24% | +$676K | 0.02% | 200 |
|
|
2021
Q2 | $2.65M | Buy |
11,555
+3,026
| +35% | +$608K | 0.01% | 211 |
|
|
2021
Q1 | $1.59M | Buy |
8,529
+343
| +4% | +$67.1K | 0.01% | 231 |
|
|
2020
Q4 | $1.38M | Buy |
8,186
+2,644
| +48% | +$395K | 0.01% | 229 |
|
|
2020
Q3 | $821K | Buy |
5,542
+3,282
| +145% | +$508K | 0.01% | 249 |
|
|
2020
Q2 | $371K | Sell |
2,260
-336
| -13% | -$51.6K | ﹤0.01% | 296 |
|
|
2020
Q1 | $360K | Buy |
2,596
+195
| +8% | +$26.8K | ﹤0.01% | 333 |
|
|
2019
Q4 | $316K | Hold |
2,401
| – | – | ﹤0.01% | 354 |
|
|
2019
Q3 | $269K | Sell |
2,401
-21,350
| -90% | -$2.38M | ﹤0.01% | 349 |
|
|
2019
Q2 | $2.63M | Buy |
23,751
+2,271
| +11% | +$267K | 0.03% | 188 |
|
|
2019
Q1 | $2.75M | Sell |
21,480
-118
| -0.5% | -$14.3K | 0.03% | 168 |
|
|
2018
Q4 | $2.5M | Sell |
21,598
-27,199
| -56% | -$3.04M | 0.03% | 189 |
|
|
2018
Q3 | $5.24M | Sell |
48,797
-458
| -0.9% | -$45.8K | 0.06% | 154 |
|
|
2018
Q2 | $4.2M | Sell |
49,255
-3,918
| -7% | -$322K | 0.05% | 162 |
|
|
2018
Q1 | $4.11M | Buy |
+53,173
| New | +$4.28M | 0.05% | 167 |
|
Other funds holding LLY
VCM
VPM
Banco Santander's LLY Position: Q1 2026 in Review
Banco Santander increased its Eli Lilly (LLY) stake by 3.2% in Q1 2026, buying an estimated $3.7M and bringing the position to 116,226 shares worth $107M. The position accounts for 0.86% of the portfolio, ranked #17.
Banco Santander first reported a position in LLY in Q1 2018 and has held it in 33 quarters since. The position peaked at $121M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Banco Santander held 116,226 shares of Eli Lilly worth $107M as of Q1 2026.
- Banco Santander bought 3,646 Eli Lilly shares in Q1 2026, an estimated $3.7M.
- Eli Lilly made up 0.86% of Banco Santander's portfolio in Q1 2026, its #17 holding.
- Banco Santander first reported a position in Eli Lilly in Q1 2018 and has held it in 33 quarters since.
- Banco Santander's Eli Lilly position peaked at $121M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Banco Santander's 13F filing for Q1 2026, filed 8 May 2026.